Venous thromboembolism (VTE) risk stratification in general medical patients at an academic medical center

被引:8
|
作者
Fritz, Megan Kunka [1 ]
Kincaid, Scott E. [1 ]
Sargent, Charles G. [2 ]
Green, Amanda H. [3 ]
Davis, George A. [1 ]
机构
[1] Univ Kentucky HealthCare, Pharm Dept, 800 Rose St, Lexington, KY 40536 USA
[2] Univ Kentucky HealthCare, Div Hosp Med, 800 Rose St, Lexington, KY 40536 USA
[3] Univ Kentucky HealthCare, Dept Nursing, 800 Rose St, Lexington, KY 40536 USA
关键词
Venous thromboembolism; Classification; Risk factors; Low molecular weight heparin; Heparin; PROPHYLAXIS; PREVENTION; GUIDELINES; THROMBOSIS; MODEL;
D O I
10.1007/s11239-020-02144-1
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Hospital-acquired venous thromboembolism (VTE) is still a concern for general medical patients. Pharmacologic prophylaxis can reduce VTE incidence, but there is the potential for adverse effects. Therefore, determining which patients should receive VTE prophylaxis via risk scoring tools is essential. Limited evidence exists for the ideal venous thromboembolism risk assessment model (RAM) in hospitalized medical patients, as compared to other hospitalized patient subgroups such as surgical patients. The primary objective was to investigate the utilization and appropriateness of our institution-based VTE RAM and comparison to the Padua Prediction Score (PPS). This would allow for a gauge of provider risk assessment accuracy as well as appropriate predictive potential of the PPS or whether an alternative to the PPS should be considered. A total of 330 adult general medicine patients were included in this retrospective chart review. When compared to our institution-based VTE RAM, providers predominately stratified patients at a higher VTE risk than the institution-based VTE RAM. VTE incidence was 0.3%, which was lower than predicted. Significant discordance exists between providers' VTE risk assessment and that predicted by RAMs. Our institution-based VTE RAM appears comparable to PPS; however, it was not being utilized by providers, resulting in potentially unnecessary use of pharmacologic prophylaxis. The most appropriate venous thromboembolism risk assessment model for general medicine patients is undetermined. Our providers generally assess patients as moderate or high VTE risk, despite our institution-based RAM which typically recommends a lower risk category than provider selection. Because of provider risk assessment, more patients received pharmacologic VTE prophylaxis than would have been recommended by the RAM, which might correlate to the low incidence of VTE which was < 0.5%, although bleeding complications were not assessed in this study. A prospective study utilizing the Padua Prediction Score (or similar RAM) in general medicine patients is warranted in order to decipher the best method of predicting VTE risk.
引用
下载
收藏
页码:67 / 73
页数:7
相关论文
共 50 条
  • [1] Venous thromboembolism (VTE) risk stratification in general medical patients at an academic medical center
    Megan Kunka Fritz
    Scott E. Kincaid
    Charles G. Sargent
    Amanda H. Green
    George A. Davis
    Journal of Thrombosis and Thrombolysis, 2021, 51 : 67 - 73
  • [2] AGREEMENT OF RESIDENT VENOUS THROMBOEMBOLISM RISK STRATIFICATION USING A VTE PROTOCOL FOR HOSPITALIZED MEDICAL PATIENTS.
    Beck, M.
    Scalzi, L.
    JOURNAL OF GENERAL INTERNAL MEDICINE, 2009, 24 : 18 - 18
  • [3] Risk factors for venous thromboembolism (VTE) in medical patients in the VTE epidemiology group (VEG) study
    Cohen, A. T.
    Rietbrock, S.
    Martinez, C.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2011, 9 : 750 - 750
  • [4] To Assess the Appropriateness of the Venous Thromboembolism (VTE) Prophylaxis Agent Used Based on the VTE Risk Stratification in Hospitalised Acutely Ill Medical Patients
    Rai, Maitreyee
    Tan, Jian Liang
    Parsi, Meghana
    Duphare, Malvika
    Go, Mylene S.
    BLOOD, 2019, 134
  • [5] Venous thromboembolism (VTE) risk stratification in hospitalized cancer patients
    Hijjawi, S. B.
    Jallad, S. G.
    Ababneh, B. A.
    Abdel-Razeq, H. N.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2009, 7 : 797 - 797
  • [6] Reassessment of venous thromboembolism and bleeding risk in medical patients receiving VTE prophylaxis
    Tung, Elaine C.
    Yu, Shi-Yuan
    Shah, Kieran
    Kinkade, Angus
    Tejani, Aaron M.
    JOURNAL OF EVALUATION IN CLINICAL PRACTICE, 2020, 26 (01) : 18 - 25
  • [7] VTE Prophylaxis Across the Continuum of Care in US Medical Patients at Risk of Venous Thromboembolism
    Amin, Alpesh
    Lin, Jay
    Ryan, Amy
    BLOOD, 2009, 114 (22) : 564 - 565
  • [8] The epidemiology and treatment of medical venous thromboembolism (VTE)
    Bennett, D.
    Kruzikas, D. T.
    EUROPEAN HEART JOURNAL, 2006, 27 : 375 - 375
  • [9] Prophylaxis for Venous Thromboembolism in General Medical Patients
    Pattar, Rumi
    Kanji, Zahra
    Collins, Mark
    Boldt, Michael
    Mainra, Rajesh
    CANADIAN JOURNAL OF HOSPITAL PHARMACY, 2005, 58 (05): : 285 - 290
  • [10] The Standardization of Venous Thromboembolism (VTE) Prophylaxis in Hospitalized Patients and Increase of Physicians' Adherence to Use VTE Prophylaxis in Anadolu Medical Center
    Duman, Esra
    Alahdab, Hisam
    Cakmakci, Metin
    Enunlu, Tayfun
    CHEST, 2013, 144 (04)